Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Nov 10;7(11):972-973.
doi: 10.1021/acsmedchemlett.6b00421.

Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer Therapy

Affiliations
Editorial

Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer Therapy

Jagath Reddy Junutula et al. ACS Med Chem Lett. .
No abstract available

PubMed Disclaimer

References

    1. Sievers E. L.; Senter P. D. Antibody-Drug Conjugates in Cancer Therapy. Annu. Rev. Med. 2013, 64, 15–29. 10.1146/annurev-med-050311-201823. - DOI - PubMed
    1. Gerber H. P.; Koehn F. E.; Abraham R. T. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics. Nat. Prod. Rep. 2013, 30, 625–639. 10.1039/c3np20113a. - DOI - PubMed
    1. Donaghy H. Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates. mAbs 2016, 8, 659–671. 10.1080/19420862.2016.1156829. - DOI - PMC - PubMed
    1. https://clinicaltrials.gov.
    1. Junutula J. R.; Raab H.; Clark S.; Bhakta S.; Leipold D. D.; Weir S.; Chen Y.; Simpson M.; Tsai S. P.; Dennis M. S.; Lu Y.; Meng Y. G.; Ng C.; Yang J.; Lee C. C.; Duenas E.; Gorrell J.; Katta V.; Kim A.; McDorman K.; Flagella K.; Ross S.; Venook R.; Spencer S. D.; Wong W. L.; Lowman H. B.; Vandlen R.; Slikowski M. X.; Scheller R. H.; Polakis P.; Malllet W. Site-specific conjugation of cytotoxic drugs to antibodies substantially improves the therapeutic index. Nat. Biotechnol. 2008, 26, 925–932. 10.1038/nbt.1480. - DOI - PubMed

Publication types